Role of salivary tumour necrosis factor a in HIV-positive patients with oral manifestations

International Journal of STD and AIDS

Volumn 18, Issue 8, 2007, Pages 565-569

  Ino, Tomoaki ^a   Tada, Akio ^b   Tominaga, Akira ^a,c   Komori, Yasuo ^a   Chiba, Hiroshige ^a   Senpuku, Hidenobu ^c  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b Chiba City Health Center   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

HAART; HIV; Oral manifestations; Saliva; TNF

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA; VIRUS RNA; BIOLOGICAL MARKER;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MOUTH EXAMINATION; MOUTH ULCER; PRIORITY JOURNAL; BLOOD; CASE CONTROL STUDY; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; SALIVA; VIROLOGY;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; ORAL ULCER; RNA, VIRAL; SALIVA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 38449113323     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/095646207781439757     Document Type: Article

References (34)

1. Infections Agents Surveillance Report, In National Institute of Infectious Diseases [ www.idsc.nih.go.jp/jasr/ index-j.html ] 26:113-14
2. Pinheiro A, Macenes W, Zakrzewska JM, Robinson PG. Dental and oral lesions in HIV infected patients: a study in Brazil. Int Dent J 2004;54:131-7
3. Aarestrup FM, Guerra RO, Vieira BJ, Cunha RM. Oral manifestation of sporotrichosis in AIDS patients. Oral Dis 2001;7:134-6
4. Vassalli P. The pathophysiology of tumor necrosis factors. Annu Rev Immunol 1992;10:411-52
5. Benedict CA, Ware CF. Virus targeting of the tumor necrosis factor superfamily. Virology 2001;289:1-5
6. Emonts M, Hazelzet JA, de Groot R, Hermans PW. Host genetic determinants of Neisseria meningitides infections. Lancet Infect Dis 2003;3:565-77
7. De Rosa FG, Shaz D, Campagna AC, Dellaripa PE, Khettry U, Craven DE. Invasive pulmonary aspergillosis soon after therapy with infliximab, a tumor necrosis factor-alpha-neutralizing antibody: a possible healthcare-associated case? Infect Control Hosp Epidemiol 2003;24:477-82
8. Prell RA, Evans DE, Thalhofer C, Shi T, Funatake C, Weinberg AD. OX40-mediated memory T cell generation is TNF receptor-associated factor 2 dependent. J Immunol 2003;171:5997-6005
9. Patel V, Smith RE, Serra A, Brooke G, Howard CJ, Rigley KP. MyD-1 (SIRPalpha) regulates T cell function in the absence of exogenous danger signals, via a TNF alpha-dependent pathway. Eur J Immunol 2002;32:1865-72
10. Cannons JL, Choi Y, Watts TH. Role of TNF receptor-associated factor 2 and p38 mitogen-activated protein kinase activation during 4-1BB-dependent immune response. J Immunol 2000;165:6193-204
11. Koch W, Tiroch K, von Beckerath N, Schomig A, Kastrati A. Tumor necrosis factor-alpha, lymphotoxin-alpha and interleukin-10 gene polymorphisms and restonosis after coronary artery stenting. Cytokine 2003;24:161-71
12. Wallach D, Varfolomeev EE, Malinin NL, Goltsev YV, Kovalenko AV, Boldin MP. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol 1999;17:331-67
13. Chan FK, Chun HJ, Zheng L, Siegel RM, Bui KL, Lenardo MJ. A domain in TNF receptors that mediates ligand-independent receptor assembly and signalling. Science 2000;288:2351-4
14. Jiang Y, Woronicz JD, Liu W, Goeddel DV. Prevention of constitutive TNF receptor 1 signalling by silencer of death domains. Science 1999;283:543-6
15. Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996;14:397-440
16. Kmiec Z. Cytokines in inflammatory bowel disease. Arch Immunol Ther Exp (Warsz) 1998;46:143-55
17. De SK, Devadas K, Notkins AL. Elevated levels of tumor necrosis factor alpha (TNF-alpha) in human immunodeficiency virus type 1-transgenic mice: prevention of death by antibody to TNF-alpha. J Virol 2002;76:11710-14
18. Aries SP, Schaaf B, Hansen F, et al. Expression of complement receptors and regulatory proteins on alveolar CD4+ lymphocytes from human immunodeficiency virus-1 infected individuals. Eur Respir J 1997;10:1736-41
19. Lee BN, Ordonez N, Popek EJ, et al. Inflammatory cytokine expression is correlated with the level of human immunodeficiency virus (HIV) transcripts in HIV-infected placental trophoblastic cells. J Virol 1997;71:3628-35
20. Nottet HS, Jett M, Flanagan CR, et al. A regulatory role for astrocytes in HIV-1 encephalitis. An overexpression of eicosanoids, platelet-activating factor, and tumor necrosis factor-alpha by activated HIV-1-infected monocytes in attenuated by primary human astrocytes. J Immunol 1995;154:3567-81
21. Hittinger G, Poggi C, Delbeke E, Profizi N, Lafeuillade A. Correlation between plasma levels of cytokines and HIV-1 RNA copy number in HIV-infected patients. Infection 1998;26:100-3
22. Leigh JE, Shetty K, Fidel Jr PL. Oral opportunistic infections in HIV-positive individuals: review and role of mucosal immunity. AIDS Patient Care STDS 2004;18:443-56
23. Osborn L, Kunkel S, Nobel GJ. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc Natl Acad Sci USA 1989;86:2336-40
24. Buonagro L, Buonaguro FM, Giraldo G, Ensoli B. The human immunodeficiency virus type 1 at protein transactivates tumor necrosis factor beta gene expression through a TAR-like structure. J Virol 1994;68:2677-82
25. Moore JS, Hall SD, Jackson S. Cell-associated HIV-1 infection of salivary gland epithelial cell lines. Virology 2002;297:89-97
26. Alefantis T, Mostoller K, Jain P, Harhaj E, Grant C, Wigdahl B. Secretion of the human T cell leukemia virus type I transactivator protein tax. J Biol Chem 2005;280:17353-62
27. Zariffard MR, Novak RM, Lurain N, Sha BE, Graham P, Spear GT. Induction of tumor necrosis factor-α secretion and Toll-like receptor 2 and 4 mRNA expression by genital mucosal fluids from women with bacterial vaginosis. J Infect Dis 2005;191:1913-21
28. Yoneyama H, Harada A, Imai T, et al. Pivotal role of TARC, a CC chemokine, in bacteria-induced fulminant hepatic failure in mice. J Clin Invest 1998;102:1933-41
29. Keffer J, Probert L, Cazlaris H, et al. Transgenic mice expressing human tumor necrosis factor: a predictive genetic model of arthritis. EMBO J 1991;10:4025-31
30. Kontoyiannis D, Pasparakis M, Pizarro TT, Cominelli F, Kollias G. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity 1999;10:387-98
31. Hyrich KL, Silman AJ, Watson KD, Symmons DP. Anti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safety. Ann Rheum Dis 2004;63:1538-43
32. Miller CS, King CP, Langub MC, Kryscio RJ, Thomas MV. Salivary biomarkers of existing periodontal diseases; a cross-sectional study. J Am Dent Assoc 2006;137:322-9
33. Todorovic T, Dozic I, Vicente-Barrero M, et al. Salivary enzymes and periodontal diseases. Med Oral Patol Oral Cir Bucal 2006;11:E115-19
34. Wright AA, Katz IT. Home testing for HIV. New Engl J Med 2006;354:437-40